YWYucheng Wu

Yucheng Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yucheng Wu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Lichun Wang

    Department of Cardiology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China

    2 shared publications
  • Shufang Yang

    Department of Endocrinology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China

    2 shared publications
  • Benbingdi Gong

    1 shared publication
  • Fei Ge

    Department of Endocrinology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China

    1 shared publication
  • Hao Jiang

    Department of Cardiology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China

    1 shared publication
  • Jie Lin

    1 shared publication

Latest Publications

  • Triglyceride-Glucose Index and 10-Year Atherosclerotic Cardiovascular Disease Risk: Associations of Obesity-Related Indices in Two Nationally Representative Populations

    by Fei Ge, Qingqing Zhang, Hao Jiang, Shufang Yang, Qiuping Chen, Lichun Wang, Jinhua Gu, Yucheng Wu

    Background: The triglyceride-glucose (TyG) index has been associated with atherosclerotic cardiovascular disease (ASCVD) risk. However, the associations of TyG-related indices combined with obesity measures, including body mass index, waist circumference (WC), waist-to-height ratio, and body roundness index, with 10-year ASCVD risk across different populations remain unclear. Methods: Data from the China Health and Retirement Longitudinal Study (CHARLS; n = 8224) and the National Health and Nutrition Examination Survey (NHANES; n = 13,527) were analyzed. Weighted multivariable logistic regression, restricted cubic spline (RCS) analyses, and subgroup analyses were performed to evaluate the associations between TyG-related indices and 10-year ASCVD risk. Results: TyG and TyG-related indices were significantly associated with higher 10-year ASCVD risk in both cohorts. Nonlinear associations were observed between several TyG-related indices and ASCVD risk. Compared with the U.S. population, obesity-related TyG composite indices showed relatively stronger associations with ASCVD risk among Chinese adults. Subgroup analyses demonstrated more pronounced associations among females in the CHARLS cohort, whereas in NHANES, significant sex differences were observed only for the TyG index. Among the evaluated indices, TyG–WC showed relatively stronger associations with ASCVD risk across both datasets. Conclusion: TyG-related indices were significantly associated with 10-year ASCVD risk across Chinese and U.S. populations, although the strength of these associations varied between populations. TyG–WC may provide additional value for ASCVD risk assessment. Further longitudinal studies are warranted to validate these findings and clarify the underlying mechanisms.

  • Open Access

    Cardiac rehabilitation promotes device endothelialization and reduces peri-device leak in atrial fibrillation patients with left atrial appendage occlusion

    by Yucheng Wu, Jie Lin, Benbingdi Gong, Lichun Wang, Qiuchen Wang, Jing Zhao, Zhongbao Ruan, Kai Xu

    Aims: Left atrial appendage (LAA) occlusion for Atrial fibrillation (AF) is an invasive therapy to reduce stroke incidence and death. Cardiac rehabilitation based on exercise training has become part of the standard care for patients with heart disease. Studies are needed to evaluate the effects of cardiac rehabilitation on exercise capacity, cardiac function, quality of life (QoL), residual permeability, device endothelialization and safety in AF patients with LAA occlusion. Methods: A single-center, three-month randomized controlled trial comparing an exercise-based cardiac rehabilitation program with a control group was conducted. AF patients underwent LAA occlusions were randomized to exercise-based cardiac rehabilitation (rehabilitation group) versus usual care (control group). All patients received assessments of echocardiography, cardiac CT, scale survey, physical function and exercise capacity. All analyses were performed using SPSS 19.0. Results: Finally, 33 patients in control group and 30 patients in rehabilitation group entered final analysis. The six-minute walk distance, handgrip strength, leg strength and left ventricular systolic function increased significantly after the study period in the rehabilitation group compared with baseline, which have significant interactions with control group. Significant differences between groups were found for the mental and physical component summary scales on SF-36, also in all of the 8 subscales. The incidence of peri-device leak and incomplete endothelialization in cardiac rehabilitation group were both significantly lower than that in control group. There was no significant difference in the incidence of adverse events between the two groups. Conclusion: Cardiac rehabilitation could promote device endothelialization and reduce peri-device leak in AF patients with LAA occlusion, which also has benefits in QoL, exercise capacity, physical function and systolic left ventricular function.

  • Open Access

    Effects of incretin-based therapies on β-cell function in type 1 diabetes mellitus: a systematic review and meta-analysis

    by Yucheng Wu, Yu Lu, Shufang Yang, Qingqing Zhang

    Aim: To assess the effects of incretin-based therapies on β-cell function in patients with type 1 diabetes mellitus (T1DM). Methods: We searched the PubMed, Cochrane Library, Embase, and Web of Knowledge databases for eligible randomized clinical trials published up to July 2021. The inclusion criteria were patients with T1DM or latent autoimmune diabetes in adults, patients treated with dipeptidyl peptidase-4 inhibitors or glucagon like peptide-1 receptor agonists, and outcomes included one of the following: fasting plasma glucose, fasting C-peptide, postprandial C-peptide, C-peptide area under the curve (AUC), homeostasis model assessment for β cell function, and insulin resistance. The effects were analyzed using a random effect model with STATA 11.0. Results: Eight trials including 427 participants were included in the final analysis. A pooled analysis found no significant difference in fasting plasma glucose, fasting C-peptide, postprandial C-peptide, or C-peptide AUC between patients treated with incretin-based therapies and placebo. The two trials that reported changes in 2-hour postprandial C-peptide and two of the four trials that reported changes in C-peptide AUC reported increases after incretin-based therapies. Conclusion: This meta-analysis showed that incretin-based therapies did not preserve β-cell function in patients with T1DM.